Annual Total Assets
$22.65 M
-$7.51 M-24.89%
December 31, 2023
Summary
- As of February 20, 2025, APRE annual total assets is $22.65 million, with the most recent change of -$7.51 million (-24.89%) on December 31, 2023.
- During the last 3 years, APRE annual total assets has fallen by -$70.16 million (-75.59%).
- APRE annual total assets is now -83.05% below its all-time high of $133.61 million, reached on December 31, 2019.
Performance
APRE Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$26.89 M
-$3.07 M-10.25%
September 30, 2024
Summary
- As of February 20, 2025, APRE quarterly total assets is $26.89 million, with the most recent change of -$3.07 million (-10.25%) on September 30, 2024.
- Over the past year, APRE quarterly total assets has dropped by -$6.31 million (-18.99%).
- APRE quarterly total assets is now -79.87% below its all-time high of $133.61 million, reached on December 31, 2019.
Performance
APRE Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
APRE Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -24.9% | -19.0% |
3 y3 years | -75.6% | -57.0% |
5 y5 years | -65.7% | -53.1% |
APRE Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -60.1% | at low | -52.7% | +18.7% |
5 y | 5-year | -83.0% | at low | -79.9% | +18.7% |
alltime | all time | -83.0% | -100.0% | -79.9% | +18.7% |
Aprea Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $26.89 M(-10.2%) |
Jun 2024 | - | $29.96 M(-9.7%) |
Mar 2024 | - | $33.20 M(+46.6%) |
Dec 2023 | $22.65 M(-24.9%) | $22.65 M(-12.1%) |
Sep 2023 | - | $25.77 M(-10.2%) |
Jun 2023 | - | $28.68 M(-10.4%) |
Mar 2023 | - | $32.02 M(+6.2%) |
Dec 2022 | $30.16 M(-46.9%) | $30.16 M(-10.3%) |
Sep 2022 | - | $33.62 M(-17.4%) |
Jun 2022 | - | $40.68 M(-19.2%) |
Mar 2022 | - | $50.34 M(-11.4%) |
Dec 2021 | $56.82 M | $56.82 M(-9.1%) |
Sep 2021 | - | $62.48 M(-12.7%) |
Jun 2021 | - | $71.55 M(-11.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $80.39 M(-13.4%) |
Dec 2020 | $92.81 M(-30.5%) | $92.81 M(-9.8%) |
Sep 2020 | - | $102.83 M(-10.4%) |
Jun 2020 | - | $114.82 M(-8.2%) |
Mar 2020 | - | $125.13 M(-6.3%) |
Dec 2019 | $133.61 M(+102.4%) | $133.61 M(+133.0%) |
Sep 2019 | - | $57.34 M(-7.8%) |
Jun 2019 | - | $62.21 M(-5.8%) |
Dec 2018 | $66.02 M(+166.6%) | $66.02 M |
Dec 2017 | $24.76 M(+7748.4%) | - |
Jun 2008 | $315.50 K(-47.2%) | - |
Jun 2007 | $597.90 K(+76.6%) | - |
Jun 2006 | $338.50 K(>+9900.0%) | - |
Dec 2004 | $0.00 | - |
FAQ
- What is Aprea Therapeutics annual total assets?
- What is the all time high annual total assets for Aprea Therapeutics?
- What is Aprea Therapeutics annual total assets year-on-year change?
- What is Aprea Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly total assets year-on-year change?
What is Aprea Therapeutics annual total assets?
The current annual total assets of APRE is $22.65 M
What is the all time high annual total assets for Aprea Therapeutics?
Aprea Therapeutics all-time high annual total assets is $133.61 M
What is Aprea Therapeutics annual total assets year-on-year change?
Over the past year, APRE annual total assets has changed by -$7.51 M (-24.89%)
What is Aprea Therapeutics quarterly total assets?
The current quarterly total assets of APRE is $26.89 M
What is the all time high quarterly total assets for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly total assets is $133.61 M
What is Aprea Therapeutics quarterly total assets year-on-year change?
Over the past year, APRE quarterly total assets has changed by -$6.31 M (-18.99%)